Viruses in animal-derived starting materials could contaminate biopharmaceutical final product. A rigorous testing strategy and removal methods are reviewed.
Kate Smith
Advertisement
Kate Smith is principal scientist, development services, at BioReliance, kate.smith@bioreliance.com
Articles by Kate Smith
Advertisement
Latest Updated Articles
Clearing Viral Concerns in Animal-Derived BiomaterialsPublished: August 1st 2013 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
